AlbionVC is an early-stage tech investor that backs growing companies across various sectors.
The pre-series A round was backed by investors including AlbionVC and Ponderosa Ventures to support UK rollout and international expansion.
"We believe that Mondra’s footprinting solution can not only assist companies in meeting their scope 3 emissions reductions targets but can also support product development teams in improving products to meet the demands of end-consumers. In this way, we expect Mondra to help customers drive both impact and commercial outcomes."
The Series A round was led by AlbionVC with backing from Dowgate Capital and private investors.
"We're building a category-defining business that redefines the way humans interact with technology and that makes advanced and Generative AI realizable for enterprises. Businesses are keen to take advantage of the technology they see manifested in applications like ChatGPT, but they're struggling to figure out how to make that a reality in a business context without exposing themselves to risks. We can offer them the security, granular control, explainability and safety which is essential for all businesses, but particularly those operating in regulated sectors like insurance, healthcare, financial services and utilities."
The seed round was led by HV Capital with participation from Dutch Founders Fund, AlbionVC, FFVC, and other backers.
"Lenders are really just at the start of the digitalisation journey. kennek is here to help accelerate that journey and provide them with the tools to capitalise on the growth of the non-bank lending space."
Playground Global led the Series A round to support the firm in achieving practical quantum advantage.
"For all the advances that have been made in quantum hardware, and for all quantum computing’s promise, such progress could end up being for nothing if we can’t build the applications needed to make the technology truly useful. With our record-breaking algorithms and groundbreaking techniques, we are pushing the boundaries of what is possible in this space. With support from such a renowned deep-tech visionary as Playground, we think practical quantum advantage is achievable in years, not decades."
The financing was backed by Delin Ventures, AlbionVC, Playfair Capital and 11.2 Capital to support international growth and research programmes.
"We developed the uMed platform to help healthcare professionals more easily and efficiently run patient research and targeted care programmes at scale, improving outcomes for patients by mitigating care gaps and accelerating research. Our groundbreaking patient cohorts give researchers access to unique data and insights, accelerating development and access to new therapies, while dramatically reducing the cost of finding, engaging and collecting prospective data from patients."
